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Mycobacterium genus causes a variety of zoonotic diseases. The best known example is the zoonotic tuberculosis due toM. bovis.
Much less is known about “nontuberculous mycobacteria (NTM),” which are also associated with infections in humans. The
Mexican standard NOM-ZOO-031-1995 regulates the presence of M. bovis in cattle; however, no regulation exists for the NTM
species. The objective of this study was to isolate and identify nontuberculous mycobacteria species from cattle of local herds in
the south region of the State of Mexico through the identification and detection of the 100 bp molecular marker in the 23S rRNA
gene with subsequent sequencing of the 16S rRNA gene. Milk samples (35) and nasal exudate samples (68) were collected. From the
108 strains isolated, 39 were selected for identification.Thirteen strains isolated from nasal exudates amplified the 100 bp molecular
marker and were identified as M. neoaurum (six strains), M. parafortuitum (four strains), M. moriokaense (two strains), and M.
confluentis (one strain). ExceptM. parafortuitum, the other species identified are of public health and veterinary concern because
they are pathogenic to humans, especially those with underlying medical conditions.
1. Introduction
The genus Mycobacterium causes a wide variety of zoonotic
diseases. The best known example is zoonotic tuberculosis
due toM. bovis, forwhich cattle is themain reservoir.M. bovis
is part of the “tuberculosis complex,” which also includes
the speciesM. tuberculosis, M. africanum, M. caprae, andM.
microti [1].
Within the mycobacterial group are the “nontuberculous
mycobacteria (NTM),” which are also associated with infec-
tions in humans. The NTM are found in various environ-
mental sources such as soil, water, vegetation, animals, dairy
products, and feces and may be transmitted inadvertently by
inhalation, ingestion, or skin penetration [2].
TheMexican standardNOM-ZOO-031-1995 regulates the
presence ofM. bovis in cattle to control and eradicate bovine
tuberculosis (bTB); however, no regulation exists for the
NTM species. The official diagnosis of bovine tuberculosis
due to the presence of M. bovis at the field level is based on
the intradermal test using a purified protein derivative (tuber-
culin) [3]. Although used for several years, this test does
not provide good sensitivity and specificity. Approximately
20% of the animals with tuberculosis do not react to the test
[4], and the presence of other mycobacterial species, both
Hindawi
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2017, Article ID 6094587, 7 pages
https://doi.org/10.1155/2017/6094587
2 Canadian Journal of Infectious Diseases and Medical Microbiology
tuberculosis complex and NTM species, causes interference
that leads to false-positive and false-negative diagnoses.
Although Mexico has a regulatory standard, bTB preva-
lence in excess of 2% is reported in some areas [5]. Given
the poor specificity and sensitivity of the tuberculin test, the
actual presence ofM. bovis is likely to be lower and the infec-
tion rate of cattle by other mycobacteria is likely to be higher,
respectively. Thus, cattle breeders, veterinarians, technicians,
and employees working in the livestock industry might be
occupationally exposed to infections by M. bovis and NTM.
Very little is known about occupational exposure to zoonoses
due to NTM species because the identification of these
species was a rather difficult task prior to the development
of identification techniques based on molecular biology.
Currently, the molecular biology techniques most com-
monly used for the diagnosis of diseases caused by mycobac-
teria are restriction fragment length polymorphism (RFLP)
for the diagnosis ofM. tuberculosis [6], spoligotyping for the
diagnosis of M. bovis [7], and the detection of a 100-base
pair (bp) “specific insertion” located on the 23S rRNA gene
characteristic of Gram-positive bacteria with a high guanine-
cytosine (HGC) content, which is considered a molecular
marker for this group of bacteria [8, 9], followed by sequence
analysis of the 16S rRNAgene for the identification of bacteria
at the species level [10].
Among the NTM species identified by the aforemen-
tioned techniques are M. balnei, M. marinum, and M. platy-
poecilus, which have caused superficial and deep skin lesions
[11];M. kansasii from lung lesions [12];M. simiae from gener-
alized infections [13];M. scrofulaceum from infections of the
skin and internal organs [14]; M. szulgai associated with
pulmonary infections, osteomyelitis, tenosynovitis, and lym-
phadenitis [15]; M. ulcerans associated with subcutaneous
granulomas [16]; M. fortuitum and M. chelonae associated
with vasculitis, endocarditis, osteomyelitis, mediastinitis,
meningitis, keratitis, and hepatitis [17]; M. abscessus, associ-
ated with erythematous lesions that progressed to ulcerated
nodules [18]; and other species.
The largest percentage of the state inventory for heads of
cattle in the State of Mexico in Mexico is concentrated in the
southern region, and one of the main economic activities is
cattle ranching [19].TheMexican regulation for cattle control
NOM-ZOO-031-1995 only focuses on the tuberculin test for
the diagnosis ofM. bovis. Little is known about the presence
of NTM in the cattle of the region. Given the possibility of
identifying species of actinobacteria by detection of the 100-
base pair molecular marker on the 23S rRNA gene and the
subsequent sequencing of the 16S rRNA gene, it is possible to
identify the aforementioned NTM species.
The objective of the present study was to isolate and iden-
tify NTM species from cattle of the south region of the State
of Mexico. The Mycobacterium species were isolated from
samples of nasal exudate and bovine milk and identified by
detecting the 100-base pair molecular marker in the 23S
rRNA gene with subsequent sequencing of the 16S rRNA
gene.
2. Materials and Methods
2.1. Sampling. A sampling was performed based on the spa-
tial distribution of herds positive for bovine tuberculosis in
the state of Mexico conducted by Zaragoza et al. 2015 [20].
Four herds of cattle were selected in the south region of the
State of Mexico, one herd belonging to the Municipality of
Temascaltepec and three herds belonging to the municipality
of Zacazonapan. A total of 103 samples, 35 milk samples and
68 samples of nasal exudate, were collected. The distribution
of the number and type of samples collected in each herd is
shown in Table 1.
2.2. Obtaining Samples ofMilk and Nasal Exudate. Theudder
and nipples were cleansed with purified water and soap and
then dried with paper towels, and nipple asepsis was subse-
quently performed using swabs soaked in 70% alcohol. Five
milliliters of milk was collected directly from the nipple in
sterile 20mL vessels, discarding the initial flow.Nasal exudate
was collected directly from the inside of the nasal orifice using
a 10 cm long sterile swab, which was then submerged in an
isotonic saline solution (0.85%). Samples of milk and nasal
exudate were stored at 4∘C until processing.
2.3. Sample Processing
2.3.1. Isolation of Mycobacteria. The milk samples were cen-
trifuged at 2500 revolutions per minute (rpm) for 10 minutes.
The pellets from the milk and nasal exudate samples were
inoculated into the following culture medium selective for
mycobacteria: Stonebrink (BD BBL 220504), Middlebrook
(BDBBL 254521), andMiddlebrook (BDBBL 254521) supple-
mented with 6 g of sodium pyruvate per liter (Middlebrook-
P). The inoculated media were incubated at 37∘C for 8 weeks
and were assessed every 3 days.
2.3.2. Classification of Isolated Strains. The isolated strains
were distributed in groups according to the following char-
acteristics: colony pigmentation, growth time, and colony
characteristics (shape, consistency, texture, and pigment pro-
duction). Isolated strains were stained with Ziehl-Neelsen to
confirm the presence of acid-fast bacilli (AFB) [21].
2.4. DNA Extraction. Strains with microscopic characteris-
tics similar to mycobacteria (acid-fast positivity) and two
representative strains of each group were selected for iden-
tification. To obtain biomass, the strains were inoculated
into 30mL of Middlebrook liquid culture medium (BD BBL
254521) in 125mL flasks and incubated at 37∘C for 7 days.
The liquid medium was transferred to sterile 15mL Falcon
tubes and centrifuged for 15 minutes at 14,000 rpm.Then, the
supernatant was removed and the pellet was transferred to
1.5mL Eppendorf tubes; the tubes were then centrifuged at
14,000 rpm × 5 minutes, and the supernatant was discarded.
DNA extraction was performed on the resulting pellet using
theWizard Genomic DNA Purification kit (Promega A1120).
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Table 1: Samples collected in cattle herds in the south region of the State of Mexico.
Characteristic Herd 1 Herd 2 Herd 3 Herd 4 Total
Municipality Temascaltepec Zacazonapan Zacazonapan Zacazonapan
Breed F1 Swiss-Cebu Holstein Friesian Holstein Friesian Holstein Friesian
Geographic
location
La-19∘03󸀠13.7󸀠󸀠Lo-
100∘13󸀠36.7󸀠󸀠
La-19∘03󸀠39.5󸀠󸀠Lo-
100∘16󸀠30.9󸀠󸀠
La-19∘04󸀠0.4󸀠󸀠Lo-
100∘15󸀠11.5󸀠󸀠
La-19∘03󸀠41󸀠󸀠Lo-
100∘16󸀠06󸀠󸀠
History of bTB Prevalence 0.2%∗ Prevalence 0.2%∗ Prevalence 0.2%∗ Prevalence 0.2%∗
Samples obtained
Milk 15 20 0 0 35
Nasal exudate 0 18 23 27 68
103
La: latitude; Lo: longitude; bTB: bovine tuberculosis. ∗Information obtained from the Committee on the Promotion and Protection of Livestock of the State
of Mexico.
2.5. Detection of the Molecular Marker in the 23S rRNA Gene.
The 100 bp molecular marker located on the 23S rRNA gene
was amplified according to the methodology described by
Roller et al. (1992) using the following primers [8]:
23S InsF, 5󸀠-(AC)A(AGT)GCGTAG(AGCT)CG-
A(AT)GG-3󸀠, and 23S InsR, 5󸀠-GTG(AT)CGGTT-
T(AGCT)(GCT)GGTA-3󸀠.
The reaction was conducted using a commercial Taq
DNA polymerase (Promega M1661). The following thermal
cycle conditions were used: a predenaturation step for 5 min-
utes (94∘C); 29 cycles of denaturation for 30 seconds (94∘C),
hybridization for 45 seconds (46∘C), and elongation for 50
seconds (72∘C); and, finally, a postelongation cycle of 5
minutes (72∘C). The amplified fragments were confirmed on
a 2% agarose gel stained with ethidium bromide (SIGMA
46065).
2.6. Amplification of the 16S rRNA Gene. Strains that ampli-
fied the 100 bp phylogenetic marker were selected for 16S
rRNA sequencing analysis. The following primers were used
for the amplification:
8f: AGAGTTTGATCMTGGCTCAGand 1492r: TAC-
GGYTACCTTGTTACGACTT.
The reaction was conducted using a commercial Taq
DNA polymerase (Promega M1661). The following thermal
cycle conditions were used: one predenaturation step for 5
minutes (94∘C); 34 cycles of denaturation for 30 seconds
(94∘C), hybridization for 20 seconds (52∘C), and elongation
for 1 minute 30 seconds (72∘C); and, finally, a postelongation
cycle of 7 minutes (72∘C).
The amplified fragments were confirmed on a 1% agarose
gel stained with ethidium bromide (SIGMA 46065). The
products of this amplificationwere purified using theAmicon
Ultra Filter kit (Millipore UFC901008) and confirmed on a
1% agarose gel to verify their presence and quality.
2.7. Identification of Mycobacterium Species. The amplified
products of the 16S rRNA gene were sent to the Macrogen
Sequencing Service,Maryland, USA.The obtained sequences
were analyzed and corrected using the BioEdit program [22].
Consensus sequences were constructed from the forward
and reverse fragments, which were compared with sequences
deposited previously in GenBank of the National Center
for Biotechnology Information (NCBI) using the BLAST
program [23] and EzTaxon 2.1 [24].
2.8. Phylogenetic Analysis. Sequences of the 16S rRNA gene
were obtained for the following mycobacterial species from
the American Type Culture Collection (ATCC) and the Ger-
manCollection ofMicroorganisms andCell Cultures (DSM):
M. neoaurum ATCC25795, M. parafortuitum DSM43528, M.
moriokaense DSM44221T, and M. confluentis DSM44017T. The
sequences of the collection strains and those of the strains
isolated in the present investigation were aligned with the
BioEdit program [22]. Phylogenetic analysis was performed
using the maximum parsimony method in MEGA software
version 4 [25]. To form the root of the cladogram, the
sequence of Pantoea agglomerans DSM 3493 was used.
3. Results
The 108 strains isolated from the 103 collected samples were
distributed in 13 groups according to their macroscopic and
microscopic morphological characteristics (Table 2). Groups
11 and 12, particularly, were composed of acid-fast strains.
For identification at the species level, 39 strains were cho-
sen: 10 of them belonged to group 11 and 7 to group 12. Two
strains fromeach one of the remaining 11 groupswere selected
to complete the 39 strains. The 100 bp molecular marker was
found in the 33% (13/39) of the selected strains. For them,
the 16S rRNA gene was amplified for sequencing and iden-
tification at the species level.
The overall prevalence of NTM on the collected samples
was 12.6% (13/103) considering both milk and nasal exudate
samples. However, the specific prevalence for nasal exudate
samples was 19.1% (13/68).
According to the sequence comparison, four NTM spe-
cies of the genus Mycobacterium were identified; 64% (6/13)
of the strains had 98% and 99% of similarities with M. neo-
aurum, while 31% (4/13) had 99% similarity withM. parafor-
tuitum, 15% (2/13) had similarities of 98% and 99% with
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Table 2: Isolated strains are grouped according to their morphological characteristics and the presence of the molecular marker (100 bp) on
the 23S rRNA gene.
Group Number of Strains
Morphological characteristics Molecular marker (bp)
Macroscopic Microscopic 23S rRNA
Pigmentation Appearance Ziehl-Neelsen
1 29 Yellow Creamy − 250
2 10 White Creamy − 250
3 14 White Dry − 250
4 2 Salmon Creamy − 250
5 2 Salmon Dry − 250
6 2 White, dark Creamy − 250
7 2 White Creamy − 250
8 3 White, dark Dry − 250
9 4 White Dry − 250
10 10 White Creamy, dry − 250
11 10 White Dry + 350 and 250
12 7 Yellow Creamy + 350
13 13 White Dry − 250
−: absence of acid-fast bacilli; +: presence of acid-fast bacilli; Bp: base pairs.
Table 3: Comparison of 16S rRNA gene sequences of strains isolated from cattle with those documented in GenBank, using BLAST and
EzTaxon.
Strain Origin of the herd Culture medium Amplified fragment size (bp) Similarity (Blast) % Similarity (EzTaxon) %
1-AZ 2 Middlebrook 1428 M. neoaurum 98 M. neoaurum 98.3
2-AZ 2 Stonebrink 1408 M. neoaurum 99 M. neoaurum 99.1
3-AZ 2 Stonebrink 1428 M. neoaurum 98 M. neoaurum 98.2
5-AZ 3 Stonebrink 1416 M. neoaurum 99 M. neoaurum 99.2
8-AZ 4 Middlebrook 1415 M. neoaurum 99 M. neoaurum 99.0
12-AZ 2 Middlebrook 1415 M. neoaurum 99 M. neoaurum 99.4
4-AZ 4 Middlebrook-P 1420 M. parafortuitum 99 M. parafortuitum 98.2
9-AZ 3 Middlebrook 1415 M. parafortuitum 99 M. parafortuitum 98.9
10-AZ 4 Stonebrink 1411 M. parafortuitum 99 M. parafortuitum 98.4
11-AZ 3 Stonebrink 1414 M. parafortuitum 99 M. parafortuitum 98.2
6-AZ 2 Stonebrink 1455 M. moriokaense 99 M. moriokaense 98.2
13-AZ 4 Stonebrink 1417 M. moriokaense 98 M. moriokaense 98.2
7-AZ 2 Middlebrook-P 1420 M. confluentis 99 M. confluentis 99.1
2: Zacazonapan Holstein-F; 3: Zacazonapan Holstein-F; 4: Zacazonapan Holstein-F.
M. moriokaense, and, finally, 8% (1/13) had 99% similarity
withM. confluentis (Table 3).
The phylogenetic tree was formed with the genus Myco-
bacterium and four of its species by which the phylogenetic
relationships between the collection strains and the strains
isolated in the present investigation were observed (Figure 1).
4. Discussion
TheNTMspecies were isolated from samples of nasal exudate
only, which eliminated the samples from one of the local
farms of this study (Table 1). We found that the specific
prevalence was 19.1% in herds of the south region of the State
of Mexico. Similar studies in the United States, South Africa,
Tanzania, and Brazil reported NTM prevalence values of
3.4%, 24.5%, 7%, and 7.8%, respectively; therefore, the preva-
lence value found in this study lies within the range reported
previously [26–29]. In this study, 13 of the 39 analyzed
strains were identified as the NTM speciesM. neoaurum, M.
moriokaense, M. confluentis, andM. parafortuitum.
M. neoaurum, amember of theMycobacterium parafortu-
itum complex, is responsible for a broad spectrumof illnesses,
most of them device related infections such as Hickman
catheters, BROVIAC catheters, PICC lines [30–33], arteri-
ovenous fistula that included a polytetrafluoroethylene graft
[34], pacemakers [35], and prosthetic valve endocarditis [36].
Immunocompromised patients holding these devices are the
principal hosts, for example, patients suffering from cancer
[32] and diabetics with renal failure [31, 33, 34] and heart
problems [35]. M. neoaurum has also been isolated from
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Figure 1: Phylogenetic tree constructed by comparing the 16S rRNA gene sequences from the isolated and reference strains.
patients with urinary infections [37], meningoencephalitis
and alterations in the central nervous system [38], bacteremia
and endocarditis [39], and pulmonary infection [40, 41].
Although it has been mainly isolated from clinical cases,
there are also reports about its isolation from milk and cattle
[28, 42, 43].
M. moriokaense was isolated from sputum sample [44].
Although it is considered nonpathogenic for humans, it has
been associated with pulmonary diseases [45].M. confluentis
was isolated from sputum samples as well [46], and, along
with M. parafortuitum, both are considered nonpathogenic
species. M. confluentis, M. moriokaense, and M. neoaurum
have been isolated from different bovine and wildlife tissues
with tuberculous lesions, whereasM. parafortuitum has only
been isolated from bovine milk [26, 28, 47–49]. However,
in our work, M. parafortuitum was only isolated from nasal
exudate samples.
The nutritional requirements of mycobacteria differ
among various species, which was the reason for using differ-
ent culture media. Notably, seven of the 13 strains identified
in this study were isolated in Stonebrink medium, including
M. neoaurum, M. parafortuitum, and M. moriokaense. This
result is consistent with that described by Sepu´lveda et al.
[50] who indicated that Stonebrink medium is suitable for
the recovery of different species of the genusMycobacterium.
Garc´ıa-Martos and Garc´ıa-Agudo [51] reported that Middle-
brook medium is optimal for the isolation of actinomycetes,
which is in accord with the present investigation considering
that two species, M. neoaurum and M. parafortuitum, were
isolated in this medium. Notably,M. confluentis was isolated
only in Middlebrook medium supplemented with sodium
pyruvate; thus, the strategy of using different culture media
was appropriate because it allowed the isolation of different
species of the genusMycobacterium.
The detection of the molecular marker present in the
23S rRNA gene of Gram-positive bacteria with HGC content
allowed discrimination between strains of eubacteria and
mycobacteria. The sequencing analysis of the 16S rRNA gene
made the identification at the species level possible; therefore,
the combination of thesemethodologies is appropriate for the
identification of NTM species.
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5. Conclusions
Using the methodology described in this study, four NTM
species were isolated and identified: M. confluentis, M. mor-
iokaense, M. neoaurum, andM. parafortuitum. These species
were isolated for the first time from nasal exudates of bovines
from the south region of the State of Mexico. Three of the
identified species (M. neoaurum, M. moriokaense, and M.
confluentis) are of public health and veterinary importance.
Disclosure
This work is derived from the thesis for the degree of Doc-
torate in Health Sciences (Universidad Auto´noma del Estado
de Me´xico), registered in the PNPC-CONACYT.
Conflicts of Interest
All authors declare that they do not have any conflicts of
interest.
Acknowledgments
The authors would like to acknowledge the financial assis-
tance from the Secretary of Research and Advanced Studies
of Universidad Auto´noma del Estado de Me´xico (UAEMex)
through the following research grants: (i) “Implementation of
Geographic Information Systems and Techniques of Molec-
ular Biology, as tools in the detection and identification of
Mycobacterium spp.,” SIEA-UAEM 3486/2013CHT, and (ii)
the network “Microbiologı´a y quı´mica en las Ciencias de la
Salud,” 039/2014RIF.
References
[1] A. Aranaz, D. Cousins, A. Mateos, and L. Domı´nguez, “Ele-
vation of Mycobacterium tuberculosis subsp. caprae Aranaz et
al. 1999 to species rank as Mycobacterium caprae comb. nov.,
sp. nov,” International Journal of Systematic and Evolutionary
Microbiology, vol. 53, no. 6, pp. 1785–1789, 2003.
[2] M. H. Ho, C. K. Ho, and L. Y. Chong, “Atypical mycobacterial
cutaneous infections in Hong Kong: 10-Year retrospective
study,”HongKongMedical Journal, vol. 12, no. 1, pp. 21–26, 2006.
[3] SAGARPA, “Norma Oficial Me´xicana NOM-ZOO-031-1995
Campan˜a Nacional contra la Tuberculosis bovina (M. bovis),”
Diario Oficial de la Federacio´n, vol. 1996, pp. 12–32, 1995.
[4] O. R. G. Llamazares, C. B. G. Mart´ın, D. A. Nistal, V. A. D. L. P.
Redondo, L. D. Rodr´ıguez, and E. F. R. Ferri, “Field evaluation
of the single intradermal cervical tuberculin test and the inter-
feron-𝛾 assay for detection and eradication of bovine tuberculo-
sis in Spain,”VeterinaryMicrobiology, vol. 70, no. 1-2, pp. 55–66,
1999.
[5] SENASICA, “Informes de la Situacio´n Zoosanitaria Nacional
de 2016,” 2016, http://www.gob.mx/cms/uploads/attachment/
file/169575/SITUACION_ZOOSANITARIA_2016-11-8.pdf.
[6] M. D. Cave, K. D. Eisenach, P. F. McDermott, J. H. Bates, and
J. T. Crawford, “IS6110: Conservation of sequence in the Myco-
bacterium tuberculosis complex and its utilization in DNA
fingerprinting,” Molecular and Cellular Probes, vol. 5, no. 1, pp.
73–80, 1991.
[7] S. R. Acosta, C. C. Estrada, and S. F. Milia´n, “Tipificacio´n de
cepas deMycobacterium bovis,”Te´cnica Pecuaria enMe´xico, vol.
47, pp. 389–412, 2009.
[8] C. Roller, W. Ludwig, and K. H. Schleifer, “Gram-positive bac-
teria with a high DNA G+C content are characterized by a
common insertion within their 23S rRNA genes,” Journal of
General Microbiology, vol. 138, no. 6, pp. 1167–1175, 1992.
[9] B. A. Zaragoza, C. M. A´. Karam, M. L. P. Bustamante, T. A´.
H. Sandoval, and D. N. Ramı´rez, “Marcador molecular de acti-
nomicetos utilizado para detectarmicobacterias enmuestras de
esputo,”RevistaMexicana deCiencias Farmace´uticas, vol. 45, pp.
35–40, 2014.
[10] J. E. Clarridge, “Impact of 16S rRNA gene sequence analysis for
identification of bacteria on clinical microbiology and infec-
tious diseases,” Clinical Microbiology Reviews, vol. 17, no. 4, pp.
840–862, 2004.
[11] D. O. Sanjay, M. D. Avani, and D. O. James, “AtypicalMycobac-
terial cutaneous infections,” Dermatologic Clinics, vol. 27, no. 1,
pp. 63–73, 2009.
[12] S. Weitzul, P. J. Eichhorn, and A. G. Pandya, “Nontuberculous
mycobacterial infections of the skin,” Dermatologic Clinics, vol.
18, no. 2, pp. 359–377, 2000.
[13] H. M. Al-Abdely, S. G. Revankar, and J. R. Graybill, “Dissem-
inated Mycobacterium simiae infection in patients with AIDS,”
Journal of Infection, vol. 41, no. 2, pp. 143–147, 2000.
[14] H.-S. Jang, J.-H. Jo, C.-K. Oh et al., “Successful treatment of
localized cutaneous infection caused byMycobacterium scrofu-
laceumwith clarithromycin,” Pediatric Dermatology, vol. 22, no.
5, pp. 476–479, 2005.
[15] J. J. Meyer and S. S. Gelman, “Multifocal osteomyelitis due to
Mycobacterium szulgai in a patient with chronic lymphocytic
leukemia,” Journal of Infection, vol. 56, no. 2, pp. 151–154, 2008.
[16] D. Wagner and L. S. Young, “Nontuberculous mycobacterial
infections: a clinical review,” Journal of Infection, vol. 32, no. 5,
pp. 257–270, 2004.
[17] K. P. Redbord, D. A. Shearer, H. Gloster et al., “Atypical Myco-
bacterium furunculosis occurring after pedicures,” Journal of the
American Academy of Dermatology, vol. 54, no. 3, pp. 520–524,
2006.
[18] P. Tang, S. Walsh, C. Murray et al., “Outbreak of acupuncture-
associated cutaneousMycobacterium abscessus infections,” Jour-
nal of Cutaneous Medicine and Surgery, vol. 10, no. 4, pp. 166–
169, 2006.
[19] INEGI, “CensoAgr´ıcola,Ganadero y Forestal 2007,” 2007, http://
www.inegi.org.mx/est/contenidos/proyectos/Agro/ca2007/Re-
sultados_Agricola/default.aspx.
[20] B. A. Zaragoza, M. L. P. Bustamante, T. A´. H. Sandoval, and D.
N. Ramı´rez, “Spatial analysis of bovine tuberculosis in the State
ofMexico,Mexico,”Veterinaria Italiana, vol. 53, no. 1, pp. 29–37,
2017.
[21] OPS, “Organizacio´n Panamericana de la Salud para el diagno´s-
tico bacteriolo´gico de la tuberculosis, Normas y guı´a te´cnica,”
Parte I Basiloscopia, 2008.
[22] T. A. Hall, “BioEdit: a user. friendly biologycal sequence align-
ment editor ana analysis program for Windows 95/98/NT,”
Nucleic Acids Symposium Series, vol. 41, no. 41, pp. 95–98, 1999.
[23] S. F. Altschul, T. L. Madden, J. Zhang, Z. Zhang, W. Miller,
and D. J. Lipman, “Gapped BLAST and PSI-BLAST: a new
generation of protein database search programs,” Nucleic Acids
Research, vol. 25, no. 17, pp. 389–402, 1997.
Canadian Journal of Infectious Diseases and Medical Microbiology 7
[24] J. Chun, J.-H. Lee, Y. Jung et al., “EzTaxon: a web-based tool
for the identification of prokaryotes based on 16S ribosomal
RNA gene sequences,” International Journal of Systematic and
Evolutionary Microbiology, vol. 57, no. 10, pp. 2259–2261, 2007.
[25] K. Tamura, J. Dudley, M. Nei, and S. Kumar, “MEGA4: molec-
ular evolutionary genetics analysis (MEGA) software version
4.0,” Molecular Biology and Evolution, vol. 24, no. 8, pp. 1596–
1599, 2007.
[26] T. C.Thacker, S. Robbe-Austerman, B. Harris,M. V. Palmer, and
W. R. Waters, “Isolation of mycobacteria from clinical samples
collected in the United States from 2004 to 2011,” BMC Veteri-
nary Research, vol. 9, pp. 100–110, 2013.
[27] N. Gcebe, V. Rutten, N. C. Gey van Pittius, and A. Michel,
“Prevalence and distribution of non-tuberculous mycobacteria
(NTM) in cattle, African buffaloes (syncerus caffer) and their
environments in South Africa,” Transboundary and Emerging
Diseases, vol. 60, supplement 1, pp. 74–84, 2013.
[28] B. Z. Katale, E. V. Mbugi, L. Botha et al., “Species diversity of
non-tuberculous mycobacteria isolated from humans, livestock
and wildlife in the Serengeti ecosystem, Tanzania,” BMC Infec-
tious Diseases, vol. 14, no. 1, pp. 1–8, 616, 2014.
[29] M. M. J. Franco, A. C. Paes, M. G. Ribeiro et al., “Occurrence
of mycobacteria in bovine milk samples from both individual
and collective bulk tanks at farms and informal markets in the
southeast region of Sao Paulo, Brazil,”BMCVeterinary Research,
vol. 9, pp. 1–8, 2013.
[30] L. L. Washer, J. Riddell, J. Rider, and C. E. Chenoweth, “Myco-
bacterium neoaurum bloodstream infection: report of 4 cases
and review of the literature,” Clinical Infectious Diseases, vol. 45,
no. 2, pp. e10–e13, 2007.
[31] H. Awadh, M. Mansour, and M. Shorman, “Bacteremia with an
unusual pathogen: Mycobacterium neoaurum,” Case Reports in
Infectious Diseases, vol. 2016, Article ID 5167874, 3 pages, 2016.
[32] M. B. Davison, J. G.McCormack, Z.M. Blacklock, D. J. Dawson,
M. H. Tilse, and F. B. Crimmins, “Bacteremia caused byMyco-
bacterium neoaurum,” Journal of Clinical Microbiology, vol. 26,
pp. 762–764, 1988.
[33] C.-C. Lai, C.-K. Tan, C.-C. Chen, and P.-R. Hsueh, “Mycobac-
terium neoaurum infection in a patient with renal failure,”
International Journal of Infectious Diseases, vol. 13, no. 5, pp.
e276–e278, 2009.
[34] M. L. Becker, A. A. Suchak, J. N. Wolfe, R. Zarychanski, A.
Kabani, and L. E. Nicolle, “Mycobacterium neoaurum bactere-
mia in a hemodialysis patient,” Canadian Journal of Infectious
Diseases, vol. 14, no. 1, pp. 45–48, 2003.
[35] E. J. Hayton, O. Koch, M. Scarborough, N. Sabharwal, F. Drob-
niewski, and I. C. Bowler, “Rapidly growing mycobacteria as
emerging pathogens in bloodstream and device-related infec-
tion: a case of pacemaker infection withMycobacterium neoau-
rum,” JMM Case Reports, vol. 2, no. 1–3, 2015.
[36] A. Kumar, G. S. Pazhayattil, A. Das, andH. A. Conte, “Mycobac-
terium neoaurum causing prosthetic valve endocarditis: a case
report and review of the literature,” Brazilian Journal of Infec-
tious Diseases, vol. 18, no. 2, pp. 235–237, 2014.
[37] S. Zanetti, R. Faedda, G. Fadda et al., “Isolation and identifica-
tion of Mycobacterium neoaurum from a patient with urinary
infection,” New Microbiologica, vol. 24, no. 2, pp. 189–192, 2001.
[38] G. A. Heckman, C. Hawkins, A. Morris, L. L. Burrows, and C.
Bergeron, “Rapidly progressive dementia due toMycobacterium
neoaurum meningoencephalitis,” Emerging Infectious Diseases,
vol. 10, no. 5, pp. 924–927, 2004.
[39] B. A. Brown-Elliott, R. J. Wallace Jr., C. A. Petti et al., “Mycobac-
terium neoaurum andMycobacterium bacteremicum sp. nov. as
causes ofmycobacteremia,” Journal of ClinicalMicrobiology, vol.
48, no. 12, pp. 4377–4385, 2010.
[40] Y. Morimoto, E. D. Chan, L. Heifets, and J. M. Routes, “Pul-
monary infection with Mycobacterium neoaurum identified by
16S ribosomal DNA sequence,” Journal of Infection, vol. 54, no.
4, pp. e227–e231, 2007.
[41] C.-K. Kim, S. I. Choi, B. R. Jeon, Y.-W. Lee, Y. K. Lee, and H. B.
Shin, “Pulmonary infection caused by mycobacterium neoau-
rum: the first case in Korea,”Annals of LaboratoryMedicine, vol.
34, no. 3, pp. 243–246, 2014.
[42] S. A. Sgarioni, R. D. C.Hirata,M.HiroyukiHirata et al., “Occur-
rence of Mycobacterium bovis and non-tuberculous mycobac-
teria (NTM) in raw and pasteurized milk in the northwestern
region of Parana´, Brazil,” Brazilian Journal of Microbiology, vol.
45, no. 2, pp. 707–711, 2014.
[43] L. Padya, N. Chin’Ombe, M. Magwenzi, J. Mbanga, V. Ruhanya,
and P. Nziramasanga, “Molecular identification of mycobac-
terium species of public health importance in cattle in zimbabwe
by 16S rRNA gene sequencing,”Open Microbiology Journal, vol.
9, pp. 38–42, 2015.
[44] M. Tsukamura, I. Yano, and T. Imaeda, “Mycobacterium mor-
iokaense sp. nov., a rapidly growing, nonphotochromogenic
Mycobacterium,” International Journal of Systematic Bacteriol-
ogy, vol. 36, no. 2, pp. 333–338, 1986.
[45] A. Somoskovi andM. Salfinger, “Nontuberculous mycobacteria
in respiratory infections: advances in diagnosis and identifica-
tion,” Clinics in Laboratory Medicine, vol. 34, no. 2, pp. 271–295,
2014.
[46] P. Kirschner, A. Teske, K.-H. Schroder, R. M. Kroppenstedt, J.
Wolters, and E. C. Bottger, “Mycobacterium confluentis sp. nov,”
International Journal of Systematic Bacteriology, vol. 42, no. 2,
pp. 257–262, 1992.
[47] M. Pate, U. Zajc, D. Kusˇar et al., “Mycobacterium spp. in wild
game in Slovenia,” Veterinary Journal, vol. 208, pp. 93–95, 2016.
[48] L. Botha, N. C. Gey van Pittius, and P. D. van Helden, “Myco-
bacteria and disease in Southern Africa,” Transboundary and
Emerging Diseases, vol. 60, no. 26, pp. 147–156, 2013.
[49] J. J. CamarenaMin˜ana and R. Gonza´lez Pellicer, “Micobacterias
at´ıpicas y su implicacio´n en patologı´a infecciosa pulmonar,”
Enfermedades Infecciosas y Microbiologı´a Cl´ınica, vol. 29, no. 5,
pp. 66–75, 2011.
[50] A. Sepu´lveda, P. M. Garc´ıa, M. J. Rodr´ıguez, A. Ma´rquez, and J.
L. Puerto, “Evaluacio´n del medio de Stonebrink para la recu-
peracio´n de micobacterias,” Revista de Diagno´stico Biolo´gico,
vol. 50, pp. 189–192, 2001.
[51] P. Garc´ıa-Martos and L. Garc´ıa-Agudo, “Infecciones por mico-
bacterias de crecimiento ra´pido,” Enfermedades Infecciosas y
Microbiologı´a Cl´ınica, vol. 30, no. 4, pp. 192–200, 2012.
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
